Byrnes James R, Wolberg Alisa S
Department of Pathology and Laboratory Medicine, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Semin Thromb Hemost. 2016 Jun;42(4):445-54. doi: 10.1055/s-0036-1571343. Epub 2016 Apr 7.
Arterial and venous thromboses are major contributors to coagulation-associated morbidity and mortality. Greater understanding of mechanisms leading to thrombus formation and stability is expected to lead to improved treatment strategies. Factor XIII (FXIII) is a transglutaminase found in plasma and platelets. During thrombosis, activated FXIII cross-links fibrin and promotes thrombus stability. Recent studies have provided new information about FXIII activity during coagulation and its effects on clot composition and function. These findings reveal newly-recognized roles for FXIII in thrombosis. Herein, we review published literature on FXIII biology and effects on fibrin structure and stability, epidemiologic data associating FXIII with thrombosis, and evidence from animal models indicating FXIII has an essential role in determining thrombus stability, composition, and size.
动脉和静脉血栓形成是导致凝血相关发病率和死亡率的主要因素。对导致血栓形成和稳定性的机制有更深入的了解有望带来更好的治疗策略。凝血因子 XIII(FXIII)是一种存在于血浆和血小板中的转谷氨酰胺酶。在血栓形成过程中,活化的 FXIII 使纤维蛋白交联并促进血栓稳定性。最近的研究提供了关于 FXIII 在凝血过程中的活性及其对凝块组成和功能影响的新信息。这些发现揭示了 FXIII 在血栓形成中新认识到的作用。在此,我们综述了已发表的关于 FXIII 生物学及其对纤维蛋白结构和稳定性影响的文献、将 FXIII 与血栓形成相关联的流行病学数据,以及来自动物模型的证据,表明 FXIII 在决定血栓稳定性、组成和大小方面具有重要作用。